Latest European Patent Convention Stories
WIESBADEN, Germany, May 21, 2013 /PRNewswire/ -- Medical device manufacturer OrbusNeich Medical Inc. and its subsidiary, OrbusNeich Medical GmbH (collectively "OrbusNeich") today announced that it has enforced the seizure of over 190 stent systems from Boston Scientific Corporation (NYSE: BSX) in connection with its patent infringement proceedings in the Dusseldorf Regional Court. The products were found on May 15, 2013, at the premises of Boston Scientific Medizintechnik GmbH in...
WIESBADEN, Germany, April 30, 2013 /PRNewswire/ -- Medical device manufacturer OrbusNeich Medical Inc. and its subsidiary, OrbusNeich Medical GmbH (collectively, "OrbusNeich") today announced that it has obtained a preliminary injunction from the Dusseldorf Regional Court in patent infringement proceedings against Boston Scientific Corporation (NYSE: BSX) and its German distribution subsidiary (collectively, "Boston Scientific"). In late February, OrbusNeich filed suit in the German...
PETACH TIKVA, Israel, March 14, 2013 /PRNewswire/ -- Macrocure (http://www.macrocure.com), a biotechnology company developing advanced cell therapy products, announced today that the European Patent Office (EPO) intends to grant a European patent covering Marcocure's flagship product, CureXcell(R). The patent will be officially granted under an application titled "Activate Leukocyte Composition" and will provide patent coverage for CureXcell(R) in Europe through March 2030....
FORT LAUDERDALE, Fla., March 8, 2013 /PRNewswire/ -- OrbusNeich Medical Inc. and its subsidiary, Orbus International B.V., (collectively, "OrbusNeich") today announced that they have commenced a patent infringement lawsuit in Ireland against Boston Scientific Corporation (NYSE: BSX) and two of its Irish subsidiaries (collectively, "Boston Scientific"). The lawsuit alleges that Boston Scientific are infringing two European patents covering certain novel stent designs. The two...
FORT LAUDERDALE, Fla., Feb. 20, 2013 /PRNewswire/ -- OrbusNeich today announced that OrbusNeich Medical GmbH and Orbus International B.V., subsidiaries of OrbusNeich Medical, Inc., (collectively, "OrbusNeich") have commenced patent infringement actions in Germany and The Netherlands against Boston Scientific Corporation (NYSE: BSX) ("Boston Scientific") and its distribution affiliates in those countries. The Complaints allege that Boston Scientific infringed two European patents...
BOSTON, Jan. 7, 2013 /PRNewswire/ -- Fish & Richardson announced today that Dr. Frank Peterreins, Managing Principal of its Munich office, has translated "Patent Litigation Proceedings in Germany - A Handbook for Practitioners" from German into English. Widely considered the definitive book on German patent litigation and current German case law, this translated edition was prepared in response to the rapidly increasing volume of patent litigation cases in Germany that involve...
Integration with ANAQUA software makes global patent filing easy Boston, MA (PRWEB) December 06, 2012 Anaqua, a leading provider of intellectual asset management software and services, today announced a new service to reduce the cost and complexity of international patent filing for Anaqua clients. ANAQUA Filing Services streamlines applications for national patents under the Patent Cooperation Treaty (PCT) or the European Patent Office (EPO). ANAQUA Filing Services provide patent...
SEATTLE, Oct. 10, 2012 /PRNewswire/ -- Serials Solutions(®), a ProQuest(®) business, announced at the Frankfurt Book Fair it has signed agreements with AskZad, ciando GmbH, the European Patent Office (EPO) and Wydawnictwo Naukowe PWN SA. Researchers around the world searching for unique, authoritative academic content will be able to use the Summon discovery service to find a vast collection of international materials alongside their library's other resources. (Logo:...
SAN DIEGO, Feb. 29, 2012 /PRNewswire/ -- Essentialis, Inc. announced the February 27, 2012 filing of two new patent applications expanding the patent portfolio claiming its investigational triglyceride-lowering compound DCCR and new methods of using the drug. The first is a continuation-in-part of a current application that includes data from the recently completed clinical trial, CT013; the second is a patent filing covering certain aspects of the use of DCCR in the treatment of...
HAMM, Germany, January 26, 2012 /PRNewswire/ -- Ortho Caps GmbH today filed a notice of opposition to Align Technology's patent EP 2 263 599. With this filing, Ortho Caps has started the opposition procedure against the above patent in the European Patent Office (EPO). If successful, it could lead to the revocation of Align's patent in the designated member states of the European Patent Organisation. "This patent, describes a CAD/CAM process of fabricating dental models...
